HSC College of Pharmacy scientists named in World’s Top 2% in latest edition from Stanford University/Elsevier

Stanford University and Elsevier have released the sixth edition of their World's Top 2% of Scientists List, which features three faculty members from The University of North Texas Health Science Center at Fort Worth's College of Pharmacy.

The rankings were based on data compiled through 2022, using standardized metrics such as citations, h-index and other bibliometric indicators to identify the world's leading researchers and the top 2% of scientists in each research field worldwide.

While the h-index is commonly used to measure a scientist's impact, it has limitations as it treats all authors equally. The Stanford/Elsevier rankings address this limitation by placing more weight to first and last authors on publications. This allows scientific impact to be driven by research contributions and responsibilities.

The rankings categorize researchers into 22 scientific fields and 174 sub-fields, using established classifications from Science-Metrix and data from Elsevier's Scopus, a comprehensive database of peer-reviewed literature. In the latest edition, scientists' career-long data has been updated through 2022.

The three HSC College of Pharmacy researchers earning spots on the latest World's Top 2% of Scientists List by Stanford/Elsevier's include:

[Link]Liang Jun Yan, Ph.D. is a professor in the Department of Pharmaceutical Sciences. His research focuses on understanding the molecular mechanisms of adaptive oxidative stress response in aging and aging-related metabolic disorders. He is in the top 2% of scientists in the scientific field of Neurology & Neurosurgery.

[Link]

Michael W. Jann, Ph.D. is a professor in the Department of Pharmacotherapy. His research is focused on drug development and clinical research to treat psychiatric and geriatric patients. He is in the top 2% of scientists in the scientific field of Pharmacology & Pharmacy.

[Link]

Kyle A. Emmitte, Ph.D. is a professor and chair of the Department of Pharmaceutical Sciences. His research employs multiple types of medicinal chemistry strategies to design, synthesize and optimize biologically active small molecules to serve as in vivo probes, drug discovery leads and optimized preclinical compounds. He is the in the top 2% of scientists in the scientific field of Medicinal & Biomolecular Chemistry.

• Share
• Tweet